Agenzie

Title: Asthma Inhalers Incorrectly Used by Most Kids in Study
Category: Health News
Created: 4/30/2019 12:00:00 AM
Last Editorial Review: 4/30/2019 12:00:00 AM

Title: How to Tame Morning Chaos
Category: Health News
Created: 4/30/2019 12:00:00 AM
Last Editorial Review: 4/30/2019 12:00:00 AM

The U.S. Environmental Protection Agency said on Tuesday that glyphosate, a chemical in many popular weed killers, is not a carcinogen, contradicting recent decisions by U.S. juries that found that it caused cancer in people.

The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic for complicated urinary tract infections (cUTI), even as the nation grapples with the growing problem of antibiotic resistance.

Mixing energy drinks with alcohol is growing in popularity among young adults and can lead to overdrinking and related threats such as impaired driving, the report noted.

CBD products are derived from marijuana, but do not include THC, the active agent in pot that causes a "high."

High-dose radiation could be more convenient for low-risk patients, and less time-consuming and costly for the medical system.

The U.S. Food and Drug Administration on Tuesday said it would allow Philip Morris to sell a heated tobacco product called IQOS in the United States, a major victory for the international tobacco giant as it looks to sell more alternatives to traditional cigarettes.

The FDA is also requiring the addition of a "contraindication" -- advice to not use these medicines for patients who have “complex sleep behaviors,” such as sleepwalking, sleep driving and other activities, after taking them.

(Reuters Health) - While teens mostly navigate the internet with ease, they may have a tough time finding information on sexual health, a new study suggests.

The rankings include sections for best sprays, sticks and lip balms as well as those products considered safe for coral reefs.

Only 4% of children whose parents were confident in their use of an inhaler actually used the device properly.

Secretary of state should be ‘accountable’ for this

Related items from OnMedica

Doctors believe patient care has worsened
Brexit creates uncertainty for EU care workers in Scotland
Ageing medical workforce - a growing trend
Scotland to introduce legal requirement on NHS staffing
Sharp increase in vacant consultant posts in Scotland

Only 3% of GPs confident they could detect signs

Related items from OnMedica

GP gatekeepers linked to reduced patient satisfaction
GPs key to new faster cancer diagnosis standards
Cancer strategies failed to improve one-year survival
Diagnosis targets unethical says GP
Poor diabetes education leading to health complications

Help for GPs in identifying patients for referral

Related items from OnMedica

MHRA tightens licence restrictions on valproate for women
New evidence on benzodiazepine link to Alzheimer’s
New guidance on valproate use in women
GP gatekeepers linked to reduced patient satisfaction
Earlier thrombolysis improves stroke outcomes

New strategy needed for digital content, say experts

Related items from OnMedica

NHS England strips Capita of cervical screening contract
Funding cuts leave contraceptive services in jeopardy
Promise to end new HIV transmissions in England by 2030
Fragmented sexual health system is failing users
JCVI recommends universal HPV vaccination

Sharp rise in musculoskeletal conditions since the millennium

Related items from OnMedica

Transforming MSK care and patient outcomes
Opioid or muscle relaxant no extra benefit for back pain
New guidance launched for hip replacement
Single-dose malaria drug eliminates parasite from liver
Self-help graded exercise programme may curb CFS fatigue

The test tracks changes in the electrical pattern of a person's cells, and it accurately flagged all CFS patients in a small group of 40 people, researchers report.

LATE causes memory loss and problems with thinking and reasoning, but on autopsy, doctors don’t find the Alzheimer’s-linked protein clumps known as plaques and tangles in the brain.

The U.S. Justice Department has joined a pair of whistleblower lawsuits alleging a drugmaker now owned by Mallinckrodt Plc improperly promoted an expensive multiple sclerosis treatment and paid kickbacks to doctors who prescribed the drug.